• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Author's Reply to ''Comment on 'Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta-Analysis''.

作者信息

Qiao Weiqiang, Jia Zhiqiang, Guo Wanying, Liu Qipeng, Guo Xiao, Deng Miao

机构信息

Department of Breast Surgery, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Jinghua Road No. 24, Luoyang, 471000, China.

Henan Provincial Key Medical Laboratory of Tissue Damage and Repair, The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang, China.

出版信息

Mol Diagn Ther. 2025 Mar;29(2):273-276. doi: 10.1007/s40291-024-00765-3. Epub 2025 Jan 2.

DOI:10.1007/s40291-024-00765-3
PMID:39745658
Abstract
摘要

相似文献

1
Author's Reply to ''Comment on 'Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta-Analysis''.作者对《关于“人类白细胞抗原I类表达在乳腺癌中的预后及临床意义：一项荟萃分析”的评论》的回复
Mol Diagn Ther. 2025 Mar;29(2):273-276. doi: 10.1007/s40291-024-00765-3. Epub 2025 Jan 2.
2
Comment on "Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta‑Analysis".对“人类白细胞抗原I类表达在乳腺癌中的预后及临床意义：一项荟萃分析”的评论
Mol Diagn Ther. 2024 Mar;28(2):237-238. doi: 10.1007/s40291-024-00700-6. Epub 2024 Feb 20.
3
Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta-Analysis.乳腺癌中人类白细胞抗原 I 类表达的预后和临床意义：一项荟萃分析。
Mol Diagn Ther. 2023 Sep;27(5):573-582. doi: 10.1007/s40291-023-00664-z. Epub 2023 Jul 18.
4
Reply to 'Comment on 'The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis''.对《关于“维生素D途径基因变异和循环25-羟基维生素D对癌症结局的影响：系统评价和荟萃分析”的评论》的回复
Br J Cancer. 2017 Jul 11;117(2):e4. doi: 10.1038/bjc.2017.185. Epub 2017 Jun 22.
5
Author's reply: Comment on "comparative efficacy of different bowel preparations for colonoscopy: A network meta-analysis".作者回复：对“不同肠道准备方法用于结肠镜检查的比较疗效：一项网状荟萃分析”的评论
Dig Liver Dis. 2025 Apr;57(4):935. doi: 10.1016/j.dld.2025.01.184. Epub 2025 Jan 27.
6
Reply to the comment on "Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysis'' by Kahvecioglu et al.对Kahvecioglu等人对“剂量递增再照射改善局部复发性头颈癌的预后——一项大型多中心分析结果”的评论的回复
Radiother Oncol. 2023 Nov;188:109866. doi: 10.1016/j.radonc.2023.109866. Epub 2023 Aug 22.
7
Author's reply to: Comment on: "Meta-analysis of ocular axial length in newborns and infants until three years of age".作者对《关于三岁及以下新生儿和婴儿眼轴长度的荟萃分析》评论的回复。
Surv Ophthalmol. 2022 Mar-Apr;67(2):633-635. doi: 10.1016/j.survophthal.2021.11.011. Epub 2021 Dec 4.
8
Comment to: Non-specific clinical presentations are not prognostic and do not anticipate hospital length of stay or resource utilization: Author's reply.对《非特异性临床表现不具有预后价值，也无法预测住院时间或资源利用情况：作者回复》的评论
Eur J Intern Med. 2021 Sep;91:87. doi: 10.1016/j.ejim.2021.07.003. Epub 2021 Jul 21.
9
Author's Reply to Nunes et al.: Comment on: "Comparison of Periodized and Non-Periodized Resistance Training on Maximal Strength: A Meta-Analysis".作者对努内斯等人的回复：对《周期性与非周期性抗阻训练对最大力量影响的比较：一项荟萃分析》的评论
Sports Med. 2018 Feb;48(2):495-496. doi: 10.1007/s40279-017-0822-z.
10
Author's reply to Paravidino et al.: Comment on: "Effect of exercise training on non-exercise physical activity: a systematic review and meta-analysis of randomized controlled trials".作者对帕拉维迪诺等人的回复：对《运动训练对非运动身体活动的影响：随机对照试验的系统评价和荟萃分析》的评论
Sports Med. 2017 Oct;47(10):2131-2134. doi: 10.1007/s40279-017-0756-5.

本文引用的文献

1
Comment on "Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta‑Analysis".对“人类白细胞抗原I类表达在乳腺癌中的预后及临床意义：一项荟萃分析”的评论
Mol Diagn Ther. 2024 Mar;28(2):237-238. doi: 10.1007/s40291-024-00700-6. Epub 2024 Feb 20.
2
Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy.激素受体阳性、HER2 阴性乳腺癌中的人类白细胞抗原 I 类：与新辅助化疗后反应和生存的相关性。
Breast Cancer Res. 2019 Dec 11;21(1):142. doi: 10.1186/s13058-019-1231-z.
3
BCIP: a gene-centered platform for identifying potential regulatory genes in breast cancer.
BCIP：一种基于基因的平台，用于鉴定乳腺癌中的潜在调控基因。
Sci Rep. 2017 Mar 22;7:45235. doi: 10.1038/srep45235.
4
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.系统评价与Meta分析的首选报告项目：PRISMA声明
Int J Surg. 2010;8(5):336-41. doi: 10.1016/j.ijsu.2010.02.007. Epub 2010 Feb 18.